express medicals p.l.c.
express medicals p.l.c. Company Information
Company Number
03211156
Next Accounts
Dec 2025
Shareholders
dr daniel hegarty
Group Structure
View All
Industry
Other human health activities
Registered Address
no 8 city business centre, london, SE16 2XB
Website
www.expressmedicals.co.ukexpress medicals p.l.c. Estimated Valuation
Pomanda estimates the enterprise value of EXPRESS MEDICALS P.L.C. at £6.9m based on a Turnover of £8.8m and 0.78x industry multiple (adjusted for size and gross margin).
express medicals p.l.c. Estimated Valuation
Pomanda estimates the enterprise value of EXPRESS MEDICALS P.L.C. at £10.6m based on an EBITDA of £1.8m and a 6.04x industry multiple (adjusted for size and gross margin).
express medicals p.l.c. Estimated Valuation
Pomanda estimates the enterprise value of EXPRESS MEDICALS P.L.C. at £6.1m based on Net Assets of £2.6m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Express Medicals P.l.c. Overview
Express Medicals P.l.c. is a live company located in london, SE16 2XB with a Companies House number of 03211156. It operates in the other human health activities sector, SIC Code 86900. Founded in June 1996, it's largest shareholder is dr daniel hegarty with a 100% stake. Express Medicals P.l.c. is a mature, mid sized company, Pomanda has estimated its turnover at £8.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Express Medicals P.l.c. Health Check
Pomanda's financial health check has awarded Express Medicals P.L.C. a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 4 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
4 Weak
Size
annual sales of £8.8m, make it larger than the average company (£693.5k)
£8.8m - Express Medicals P.l.c.
£693.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a similar rate (8%)
9% - Express Medicals P.l.c.
8% - Industry AVG
Production
with a gross margin of 62.8%, this company has a lower cost of product (39.1%)
62.8% - Express Medicals P.l.c.
39.1% - Industry AVG
Profitability
an operating margin of 18.1% make it more profitable than the average company (5.4%)
18.1% - Express Medicals P.l.c.
5.4% - Industry AVG
Employees
with 100 employees, this is above the industry average (18)
100 - Express Medicals P.l.c.
18 - Industry AVG
Pay Structure
on an average salary of £38.1k, the company has a higher pay structure (£27.5k)
£38.1k - Express Medicals P.l.c.
£27.5k - Industry AVG
Efficiency
resulting in sales per employee of £88k, this is more efficient (£49.1k)
£88k - Express Medicals P.l.c.
£49.1k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is later than average (20 days)
42 days - Express Medicals P.l.c.
20 days - Industry AVG
Creditor Days
its suppliers are paid after 30 days, this is slower than average (16 days)
30 days - Express Medicals P.l.c.
16 days - Industry AVG
Stock Days
it holds stock equivalent to 7 days, this is less than average (15 days)
7 days - Express Medicals P.l.c.
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 70 weeks, this is less cash available to meet short term requirements (109 weeks)
70 weeks - Express Medicals P.l.c.
109 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34.9%, this is a higher level of debt than the average (25.1%)
34.9% - Express Medicals P.l.c.
25.1% - Industry AVG
EXPRESS MEDICALS P.L.C. financials
Express Medicals P.L.C.'s latest turnover from June 2024 is £8.8 million and the company has net assets of £2.6 million. According to their latest financial statements, Express Medicals P.L.C. has 100 employees and maintains cash reserves of £1.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8,803,935 | 7,889,139 | 6,218,157 | 6,789,138 | 4,944,135 | 5,400,010 | 4,915,897 | 5,061,875 | 4,808,005 | 3,613,985 | 3,512,332 | 3,008,008 | 2,861,402 | ||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 3,271,886 | 2,932,408 | 2,270,372 | 2,270,442 | 1,880,154 | 2,219,448 | 2,776,538 | 2,488,834 | 2,186,653 | 1,742,552 | 1,638,617 | 1,330,467 | 1,255,695 | ||
| Gross Profit | 5,532,049 | 4,956,731 | 3,947,785 | 4,518,696 | 3,063,981 | 3,180,562 | 2,139,359 | 2,573,041 | 2,621,352 | 1,871,433 | 1,873,715 | 1,677,541 | 1,605,707 | ||
| Admin Expenses | 3,936,021 | 3,463,310 | 2,845,027 | 2,595,920 | 2,399,954 | 2,519,233 | 2,123,803 | 2,166,946 | 1,904,149 | 1,583,757 | 1,402,886 | 1,297,436 | 1,205,428 | ||
| Operating Profit | 1,596,028 | 1,493,421 | 1,102,758 | 1,922,776 | 664,027 | 661,329 | 15,556 | 406,095 | 717,203 | 287,676 | 470,829 | 380,105 | 400,279 | ||
| Interest Payable | 1,367 | 5,992 | 10,147 | 37,621 | |||||||||||
| Interest Receivable | 27,561 | 7,307 | 44 | 91 | 1,362 | 517 | 979 | 1,118 | 5,576 | 454 | 535 | 144 | 256 | ||
| Pre-Tax Profit | 1,623,589 | 1,500,728 | 1,102,802 | 1,921,500 | 659,397 | 651,699 | -21,086 | 407,213 | 722,779 | 288,130 | 471,364 | 380,249 | 228,035 | ||
| Tax | -307,745 | -61 | -231,189 | -364,175 | -131,796 | -129,476 | -56,587 | -34,441 | -178,304 | -54,594 | -111,359 | -91,041 | -76,279 | ||
| Profit After Tax | 1,315,844 | 1,500,667 | 871,613 | 1,557,325 | 527,601 | 522,223 | -77,673 | 372,772 | 544,475 | 233,536 | 360,005 | 289,208 | 151,756 | ||
| Dividends Paid | 1,090,000 | 1,030,000 | 620,000 | 90,000 | 102,000 | 240,000 | 300,000 | 195,000 | 240,000 | 219,000 | 15,000 | ||||
| Retained Profit | 225,844 | 470,667 | 251,613 | 1,557,325 | 527,601 | 432,223 | -179,673 | 132,772 | 244,475 | 38,536 | 120,005 | 70,208 | 136,756 | ||
| Employee Costs | 3,809,138 | 3,197,854 | 2,597,288 | ||||||||||||
| Number Of Employees | 100 | 86 | 77 | 67 | 68 | 69 | 69 | 70 | |||||||
| EBITDA* | 1,754,246 | 1,619,534 | 1,189,254 | 1,994,578 | 744,363 | 763,432 | 132,201 | 538,507 | 799,169 | 371,859 | 544,398 | 451,964 | 471,116 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 756,125 | 742,314 | 683,531 | 599,449 | 600,760 | 603,670 | 683,130 | 771,524 | 815,013 | 894,439 | 810,130 | 666,999 | 404,768 | 361,361 | 370,405 |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 756,125 | 742,314 | 683,531 | 599,449 | 600,760 | 603,670 | 683,130 | 771,524 | 815,013 | 894,439 | 810,130 | 666,999 | 404,768 | 361,361 | 370,405 |
| Stock & work in progress | 68,821 | 59,918 | 24,096 | 36,878 | 65,581 | 12,047 | 8,464 | 13,740 | 15,812 | 16,322 | 17,294 | 20,674 | 5,674 | 5,674 | 5,674 |
| Trade Debtors | 1,035,278 | 895,805 | 902,928 | 768,722 | 474,948 | 838,602 | 643,037 | 536,672 | 582,112 | 631,962 | 619,699 | 493,172 | 496,582 | 420,569 | 425,678 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 392,486 | 432,474 | 293,964 | 289,355 | 269,264 | 87,874 | 32,460 | 25,393 | 21,812 | 79,575 | |||||
| Cash | 1,728,619 | 1,583,029 | 1,046,002 | 1,314,790 | 952,127 | 358,617 | 214,386 | 214,911 | 675,931 | 417,868 | 495,271 | 219,096 | 308,776 | 242,545 | 101,213 |
| misc current assets | 122,448 | 126,455 | 136,212 | 151,188 | 143,292 | 143,854 | 110,593 | 114,509 | 99,223 | 82,047 | |||||
| total current assets | 3,225,204 | 2,971,226 | 2,266,990 | 2,409,745 | 1,761,920 | 1,419,588 | 1,024,802 | 926,928 | 1,446,855 | 1,289,019 | 1,276,118 | 843,535 | 925,541 | 768,011 | 614,612 |
| total assets | 3,981,329 | 3,713,540 | 2,950,521 | 3,009,194 | 2,362,680 | 2,023,258 | 1,707,932 | 1,698,452 | 2,261,868 | 2,183,458 | 2,086,248 | 1,510,534 | 1,330,309 | 1,129,372 | 985,017 |
| Bank overdraft | 77,235 | 103,096 | 132,376 | 135,847 | 55,750 | 55,750 | 55,750 | 22,999 | |||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 275,695 | 226,640 | 196,425 | 198,232 | 190,739 | 258,458 | 203,740 | 256,966 | 273,228 | 201,595 | 166,402 | 189,401 | 154,872 | 145,900 | 79,730 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,000,728 | 1,017,459 | 771,300 | 1,113,661 | 699,410 | 608,378 | 640,459 | 577,941 | 679,577 | 457,065 | 421,957 | 217,748 | 293,899 | 233,660 | 235,878 |
| total current liabilities | 1,276,423 | 1,244,099 | 967,725 | 1,311,893 | 967,384 | 969,932 | 976,575 | 970,754 | 1,008,555 | 714,410 | 644,109 | 430,148 | 448,771 | 379,560 | 315,608 |
| loans | 35,320 | 106,563 | 200,051 | 318,961 | 171,712 | 218,660 | 264,028 | 165,817 | |||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 111,824 | 102,203 | 86,225 | 52,343 | 52,343 | 46,731 | 63,497 | 63,497 | 65,197 | 54,311 | 56,428 | 37,361 | 42,866 | 31,145 | 20,950 |
| total long term liabilities | 111,824 | 102,203 | 86,225 | 52,343 | 87,663 | 153,294 | 263,548 | 382,458 | 236,909 | 272,971 | 320,456 | 203,178 | 42,866 | 31,145 | 20,950 |
| total liabilities | 1,388,247 | 1,346,302 | 1,053,950 | 1,364,236 | 1,055,047 | 1,123,226 | 1,240,123 | 1,353,212 | 1,245,464 | 987,381 | 964,565 | 633,326 | 491,637 | 410,705 | 336,558 |
| net assets | 2,593,082 | 2,367,238 | 1,896,571 | 1,644,958 | 1,307,633 | 900,032 | 467,809 | 345,240 | 1,016,404 | 1,196,077 | 1,121,683 | 877,208 | 838,672 | 718,667 | 648,459 |
| total shareholders funds | 2,593,082 | 2,367,238 | 1,896,571 | 1,644,958 | 1,307,633 | 900,032 | 467,809 | 345,240 | 1,016,404 | 1,196,077 | 1,121,683 | 877,208 | 838,672 | 718,667 | 648,459 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,596,028 | 1,493,421 | 1,102,758 | 1,922,776 | 664,027 | 661,329 | 15,556 | 406,095 | 717,203 | 287,676 | 470,829 | 380,105 | 400,279 | ||
| Depreciation | 158,218 | 126,113 | 86,496 | 71,802 | 80,336 | 102,103 | 110,213 | 93,994 | 116,645 | 132,412 | 81,966 | 84,183 | 73,569 | 71,859 | 70,837 |
| Amortisation | |||||||||||||||
| Tax | -307,745 | -61 | -231,189 | -364,175 | -131,796 | -129,476 | -56,587 | -34,441 | -178,304 | -54,594 | -111,359 | -91,041 | -76,279 | ||
| Stock | 8,903 | 35,822 | -12,782 | -28,703 | 53,534 | 3,583 | -5,276 | -2,072 | -510 | -972 | -3,380 | 15,000 | 5,674 | ||
| Debtors | 99,485 | 131,387 | 138,815 | 313,865 | -182,264 | 250,979 | 113,432 | -41,859 | -107,613 | 91,838 | 126,527 | -3,410 | 76,013 | -5,109 | 425,678 |
| Creditors | 49,055 | 30,215 | -1,807 | 7,493 | -67,719 | 54,718 | -53,226 | -16,262 | 71,633 | 35,193 | -22,999 | 34,529 | 8,972 | 66,170 | 79,730 |
| Accruals and Deferred Income | -16,731 | 246,159 | -342,361 | 414,251 | 91,032 | -32,081 | 62,518 | -101,636 | 222,512 | 35,108 | 204,209 | -76,151 | 60,239 | -2,218 | 235,878 |
| Deferred Taxes & Provisions | 9,621 | 15,978 | 33,882 | 5,612 | -16,766 | -1,700 | 10,886 | -2,117 | 19,067 | -5,505 | 11,721 | 10,195 | 20,950 | ||
| Cash flow from operations | 1,380,058 | 1,744,616 | 521,746 | 1,766,985 | 770,222 | 385,265 | 488,768 | 481,384 | 697,995 | 258,548 | 437,958 | 440,179 | 300,043 | ||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -35,320 | -71,243 | -93,488 | -118,910 | 147,249 | -46,948 | -45,368 | 98,211 | 165,817 | ||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 27,561 | 7,307 | 44 | -1,276 | -4,630 | -9,630 | -36,642 | 1,118 | 535 | 144 | 256 | ||||
| cash flow from financing | 27,561 | 7,307 | 44 | -1,256,596 | -195,873 | -103,118 | -83,590 | -102,628 | 535 | 144 | 511,959 | ||||
| cash and cash equivalents | |||||||||||||||
| cash | 145,590 | 537,027 | -268,788 | 362,663 | 593,510 | 144,231 | -525 | -461,020 | 258,063 | -77,403 | 276,175 | -89,680 | 66,231 | 141,332 | 101,213 |
| overdraft | -77,235 | -25,861 | -29,280 | -3,471 | 80,097 | 32,751 | 22,999 | ||||||||
| change in cash | 145,590 | 537,027 | -268,788 | 439,898 | 619,371 | 173,511 | 2,946 | -541,117 | 258,063 | -77,403 | 243,424 | -112,679 | 66,231 | 141,332 | 101,213 |
express medicals p.l.c. Credit Report and Business Information
Express Medicals P.l.c. Competitor Analysis
Perform a competitor analysis for express medicals p.l.c. by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SE16 area or any other competitors across 12 key performance metrics.
express medicals p.l.c. Ownership
EXPRESS MEDICALS P.L.C. group structure
Express Medicals P.L.C. has no subsidiary companies.
Ultimate parent company
EXPRESS MEDICALS P.L.C.
03211156
express medicals p.l.c. directors
Express Medicals P.L.C. currently has 4 directors. The longest serving directors include Dr Daniel Hegarty (Jun 1998) and Mr Gary Morley (Feb 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Daniel Hegarty | England | 69 years | Jun 1998 | - | Director |
| Mr Gary Morley | England | 67 years | Feb 2015 | - | Director |
| Mrs Jane MacKenzie-Lawrie | 64 years | Apr 2023 | - | Director | |
| Mr Michael Flynn | 59 years | Sep 2024 | - | Director |
P&L
June 2024turnover
8.8m
+12%
operating profit
1.6m
+7%
gross margin
62.9%
+0.01%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
2.6m
+0.1%
total assets
4m
+0.07%
cash
1.7m
+0.09%
net assets
Total assets minus all liabilities
express medicals p.l.c. company details
company number
03211156
Type
Public limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 1996
age
29
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2024
previous names
express medicals limited (December 2022)
accountant
-
auditor
PRENTIS & CO LLP
address
no 8 city business centre, london, SE16 2XB
Bank
-
Legal Advisor
-
express medicals p.l.c. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to express medicals p.l.c.. Currently there are 1 open charges and 5 have been satisfied in the past.
express medicals p.l.c. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EXPRESS MEDICALS P.L.C.. This can take several minutes, an email will notify you when this has completed.
express medicals p.l.c. Companies House Filings - See Documents
| date | description | view/download |
|---|
